Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by Mil_Man54on Feb 03, 2022 6:16pm
49 Views
Post# 34395226

RE:RE:RE:FSD Pharma Facility Valued at 420 million ??????

RE:RE:RE:FSD Pharma Facility Valued at 420 million ??????
Walter333 wrote:
JAKPUG4LIFE wrote: Anyone ever wondered or knew who the specialist might have been? They could very well be part of a lawsuit as well would you not think assesing it at such a ridiculous price
Pyritetrap wrote:

SO WHY ARE THEY SELLING IT NOW FOR ONLY ABOUT 10 MILLION

WHAT IS DAVID UP TO?????


FSD Pharma Facility Valued at $105,000,000 With 3,000,000 ft Expansion Assessed at $420,000,000

 

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the Company’s facility and land located at 520 William Street in Cobourg, Ontario has a Fair Market Value of $105,000,000 according to a recent Comprehensive Property Value Assessment by a commercial real estate assessment specialist issued on November 20, 2018.

FSD Pharma facility valued at $105,000,000 with 3,000,000 foot expansion assessed at $420,000,000

Tweet this

Due to the nature of the property, the current value assessment was conducted using the Cost Approach and incorporated property improvements of over $10,000,000 by the Company since acquisition, ongoing Joint Venture Capital Improvements by Auxly Cannabis Group Inc. (TSX.V – XLY) of over $50,000,000 and Government-Issued Licenses for the production and sale of cannabis attached to the footprint of the property. Also considered in the assessment were unique features of the site, including its classification as a special use/purpose government food-grade facility with train access directly on the property, an on-site power generating station, and substantial ongoing capital renovations under Health Canada Guidelines and Specifications.

In the opinion of the commercial real estate assessment specialist, the property as a whole at the time of completion and operation of approximately 3,000,000 square feet would have an overall property value of an estimated $420,000,000 (at an average cost of 250 dollars per square foot to build out). At full capacity, the facility is expected to produce 400 million grams of dried cannabis flower per year.

Dr. Raza Bokhari, interim CEO and Co-Chairman of the Board commented, “The Company continues to collaborate with our partner Auxly to build out our Cobourg facility, which currently includes 620,000 square feet of building space available with a phased-in plan over the next 6 years to build out a total of 3,896,000 square feet. We are pleased to see that our ongoing efforts are paying off, both in terms of grow space expansion and capital investment.”

 

https://www.businesswire.com/news/home/20181128005094/en/FSD-Pharma-Facility-Valued-at-105000000-With-3000000-ft-Expansion-Assessed-at-420000000


 


AD most likely had someone assess it just as he had his own team assess the numbers in this video with his rebuttal to the seeking alpha article about his rampant destruction of shareholder value. Yeah, like numbers provided by your own team as opposed to an independent third parties findings is believable. Give me a break, what a goober. https://youtu.be/vQ7jEWjt7Og


<< Previous
Bullboard Posts
Next >>